Skip to content
HeyJared

Int J Infect Dis

Reporter · US

Indexed articles, last 90 days
4
Latest publication
Sep 17, 2026
Outlet visibility, for Medscape
Top 50K sites
Earliest in this view
Sep 2, 2026

Latest articles

  1. Article · Sep 17, 2026 · Int J Infect Dis. 2026;:109100.

    Shingles Vaccine Boosts Antibodies in People Living With HIV (opens the original)

    Excerpt · English

    Read excerpt

    A recombinant zoster vaccine induced robust antibody responses in people living with HIV (PLWH) regardless of their CD4 count, with nearly all participants achieving humoral vaccine response after two doses. However, cell-mediated immunity was weaker in PLWH than in those without HIV. "[The study] findings support the current guidelines recommending administration of RZV [recombinant zoster vaccine] to PLWH, regardless of the CD4 count," the authors wrote. The study was led by Min-Kyung Kim, Nat

  2. Article · Sep 8, 2026 · Int J Infect Dis. 2026-09-08;:109092.

    Urine Culture Can Speed Urosepsis Pathogen Detection (opens the original)

    Excerpt · English

    Read excerpt

    Urine culture (UC) identified the same pathogen as blood culture (BC) in more than half of suspected urosepsis episodes and provided results faster, with more than 50% of UC reports available within 1 day. Concordant episodes showed shorter BC time-to-positivity and were associated with faster decline of inflammatory markers and better survival. "[The study] findings support the potential diagnostic and stewardship value of UC in the early management of suspected urosepsis, but prospective valid

  3. Article · Sep 2, 2026 · Int J Infect Dis. 2026-08-27;:109076.

    Nirsevimab Cuts Pediatric RSV Hospitalizations (opens the original)

    Excerpt · English

    Read excerpt

    Pediatric hospitalizations for respiratory syncytial virus (RSV) declined by more than 40% across Italy during the 2024-2025 season following regional nirsevimab immunization programs. Regions with broader eligibility criteria and earlier program initiation saw greater reductions, while those with narrower criteria or delayed rollout experienced modest declines or no clear change. "[The] present study supports a broader reflection: effective immunization likely depends not only on scientific eff

  4. Article · Sep 2, 2026 · Int J Infect Dis. 2026-08-29;:109087.

    Dengue Patients on DAPT or OAC Face More Frequent Bleeding (opens the original)

    Excerpt · Critical tone · English

    Read excerpt

    Patients with acute dengue infection who were on dual antiplatelet therapy (DAPT) or oral anticoagulant therapy (OAC) had higher rates of major bleeding within 7 days of diagnosis than those not receiving antithrombotic therapy (ATT), whereas those on single antiplatelet therapy (SAPT) showed major bleeding rates similar to those not receiving ATT at both 7 and 30 days after diagnosis. "These findings suggest that patients receiving pre-existing ATT, including those receiving SAPT, appeared to r

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 50K sites

For Medscape, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Int J Infect Dis